Screener
Kiniksa Pharmaceuticals International, plc KNSA Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.
Tagged under the XBRL concept us-gaap:InventoryNet.
The source filing: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-087545
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Cash and cash equivalents | $175,677 | $165,596 |
| Short-term investments | 350,251 | 248,478 |
| Accounts receivable, net | 23,490 | 15,594 |
| Inventory | 70,930 | 54,895 |
| Prepaid expenses and other current assets | 48,285 | 42,614 |
| Total current assets | 668,633 | 527,177 |
| Property and equipment, net | 2,575 | 1,943 |
| Operating lease right-of-use assets | 8,353 | 9,807 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Kiniksa Pharmaceuticals International, plc's inventories?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported inventories of $70.93M in Q2 2026.
- How has Kiniksa Pharmaceuticals International, plc's inventories changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's inventories increased by 47.2% year-over-year, from $48.18M to $70.93M.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.
Ask your AI about Kiniksa Pharmaceuticals International, plc's inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude